Jump to content Jump to main menu Jump to sub menu

Latest News

18 November 2009 - QED awarded pioneering Phase I Oncology trial

QED is proud to announce that it has been selected to run a complex phase I oncology trial at key sites in the United States, Spain and Belgium.  The study in patients with advanced solid tumours will be split into two parts with a safety extension phase. 

Paul Thompson, Director Business Development for QED, commented “We are very pleased to have been awarded this very important and challenging study.  The trial further enhances our strong oncology trial experience and gives us an opportunity to be involved in some truly pioneering and innovative clinical research”.